研究论文开放获取
RNA-Targeted Therapeutics
Stanley T. Crooke, Joseph L. Witztum, C. Frank Bennett, Brenda F. Baker
Ionis Pharmaceuticals (United States) University of California San Diego
内容与影响
摘要 · 节选
暂未获取摘要。可打开原文或 PDF，后续可基于全文生成更完整的速读。
逐年被引趋势
124620
18
19
20
21
12422
23
24
25
26
关键指标
806
被引次数 · OpenAlex
27.14
领域内被引倍数
同类平均 = 1
同类平均 = 1
前 0.2%
引用位次
同领域 · 同年份 · 同类型
同领域 · 同年份 · 同类型
193
参考文献
Google Scholar 与 OpenAlex 的被引统计范围不同，数值存在差异属正常。
AI 辅助阅读
依据：文献信息
论文问答
依据：文献信息 · 当前未解析全文
回答优先基于摘要、文献信息与可获取全文；依据不足时会明确说明。
学术脉络
学科主题
生物医学RNA Interference and Gene Delivery
RNA Research and Splicing · RNA modifications and cancer
参考文献 193
Toxicological and Pharmacokinetic Properties of QPI-1007, a Chemically Modified Synthetic siRNA Targeting Caspase 2 mRNA, Following Intravitreal Injection
被引 86Elisabeth C.R. Solano, Douglas J. Kornbrust, Amber Beaudry · Nucleic Acid Therapeutics · 2014
A Phase I Open Label, Dose Escalation Trial Of QPI-1007 Delivered By A Single Intravitreal (IVT) Injection To Subjects With Low Visual Acuity And Acute Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
被引 8Andrew N. Antoszyk, Bradley J. Katz, Rishi P. Singh · 2013
Phase 2 of bamosiran (SYL040012), a novel RNAi based compound for the treatment of increased intraocular pressure associated to glaucoma
被引 16Victoria González, Kadi Palumaa, Krista Turman · 2014
此处列出前 3 条
施引文献 806
Therapeutic siRNA: state of the art
被引 1,537Bo Hu, Liping Zhong, Yuhua Weng · Signal Transduction and Targeted Therapy · 2020
Circular RNAs: Characterization, cellular roles, and applications
被引 1,128Chu‐Xiao Liu, Ling‐Ling Chen · Cell · 2022
Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
被引 1,027Sotirios Tsimikas, Ewa Karwatowska‐Prokopczuk, Ioanna Gouni‐Berthold · New England Journal of Medicine · 2020
按被引量排序，此处列出前 3 条